Valuation: genOway

Market Cap 22.13M 25.29M 20.33M 18.95M 35.87M 2.41B 36.54M 245M 94.9M 1.18B 95M 92.91M 4.08B P/E 2024 *
-
P/E 2025 -
Enterprise Value 28.85M 32.97M 26.5M 24.71M 46.76M 3.15B 47.64M 319M 124M 1.54B 124M 121M 5.32B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 week+2.56%
Current month+1.27%
1 month+0.42%
3 months-4.76%
6 months-11.44%
Current year-11.44%
1 week 2.31
Extreme 2.31
2.45
1 month 2.31
Extreme 2.31
2.5
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.29
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
22-01-19Buy

Chief Executive Officer

12,500 0.1376%
21-11-16Sell

Chief Executive Officer

5,000 0.0553%
21-11-12Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.56%-27.27%-38.78% 25.2M
+0.36%+6.85%+0.11%+5.85% 48.62B
+0.92%+11.47%+412.98%+607.44% 39.86B
+1.89%+11.54%+27.32%-7.89% 33.91B
+2.38%+7.41%+21.41%+66.94% 32.32B
+1.20%+2.26%+15.60%+32.43% 24.73B
+2.51%+15.33% - - 16.63B
+2.58%+8.74%+73.67%+132.17% 15.52B
+0.99%+3.16%+13.75%+18.88% 13.63B
-1.14%+9.41%+16.24%-30.83% 13.41B
Average +1.08%+7.16%+61.54%+87.36% 23.87B
Weighted average by Cap. +1.14%+7.73%+90.17%+131.02%

Financials

2024 2025
Net sales 27.53M 31.46M 25.3M 23.58M 44.63M 3B 45.47M 304M 118M 1.47B 118M 116M 5.07B 28.6M 32.68M 26.28M 24.49M 46.36M 3.12B 47.23M 316M 123M 1.53B 123M 120M 5.27B
Net income 1.83M 2.09M 1.68M 1.57M 2.97M 200M 3.02M 20.24M 7.85M 97.88M 7.86M 7.69M 337M 928K 1.06M 852K 795K 1.5M 101M 1.53M 10.26M 3.98M 49.6M 3.98M 3.9M 171M
Net Debt 623K 712K 572K 534K 1.01M 67.95M 1.03M 6.89M 2.67M 33.31M 2.67M 2.62M 115M 6.72M 7.68M 6.17M 5.75M 10.89M 733M 11.09M 74.29M 28.81M 359M 28.84M 28.21M 1.24B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-02 €2.400 0.00% 15,545
26-07-01 €2.400 +1.27% 3,057
26-06-30 €2.370 +0.42% 3,844
26-06-29 €2.360 +2.16% 11,740
26-06-26 €2.310 -0.86% 1,323
  1. Stock Market
  2. Stocks
  3. ALGEN Stock